1. Tan MA, Fuller M, Zabidi-Hussin ZA, Hopwood JJ, Meikle PJ. Biochemical profiling to predict disease severity in metachromatic leukodystrophy. Mol Genet Metab. 2010; 99:142–148. PMID:
19815439.
Article
2. Gieselmann V, Krägeloh-Mann I. Metachromatic leukodystrophy--an update. Neuropediatrics. 2010; 41:1–6. PMID:
20571983.
3. Baum H, Dodgson KS, Spencer B. The assay of arylsulphatases A and B in human urine. Clin Chim Acta. 1959; 4:453–455. PMID:
13663253.
Article
6. Berger J, Löschl B, Bernheimer H, Lugowska A, Tylki-Szymanska A, Gieselmann V, et al. Occurrence, distribution, and phenotype of arylsulfatase A mutations in patients with metachromatic leukodystrophy. Am J Med Genet. 1997; 69:335–340. PMID:
9096767.
Article
7. Fluharty AL, Fluharty CB, Bohne W, von Figura K, Gieselmann V. Two new arylsulfatase A (ARSA) mutations in a juvenile metachromatic leukodystrophy (MLD) patient. Am J Hum Genet. 1991; 49:1340–1350. PMID:
1684088.
8. Eto Y, Kawame H, Hasegawa Y, Ohashi T, Ida H, Tokoro T. Molecular characteristics in Japanese patients with lipidosis: novel mutations in metachromatic leukodystrophy and Gaucher disease. Mol Cell Biochem. 1993; 119:179–184. PMID:
8455580.
Article
9. Kang DH, Lee DH, Hong YH, Lee ST, Jeon BR, Lee YK, et al. Identification of a novel splicing mutation in the
ARSA gene in a patient with late-infantile form of metachromatic leukodystrophy. Korean J Lab Med. 2010; 30:516–520. PMID:
20890085.
10. Kang SY, Yum MS, Choi HW, Lee EH, Ko TS, Yoo HW. Clinical manifestations of leukodystrophies: a single center study. J Korean Child Neurol Soc. 2011; 19:115–123.
11. Lee JH, Min KB, Lee YM, Kang HC, Lee JS, Kim HD. A case of metachromatic leukodystrophy confirmed by molecular genetic analysis. J Korean Child Neurol Soc. 2011; 19:272–276.
12. Han M, Jun SH, Song SH, Park HD, Park KU, Song J. Ultra-performance liquid chromatography/tandem mass spectrometry for determination of sulfatides in dried blood spots from patients with metachromatic leukodystrophy. Rapid Commun Mass Spectrom. 2014; 28:587–594. PMID:
24519821.
Article
13. Human Genome Variation Society. Nomenclature for the description of sequence variants. Accessed on Apr 24, 2015.
http://www.hgvs.org/mutnomen/.
14. Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015; (doi:
10.1038/gim.2015.30.).
Article
15. Regis S, Corsolini F, Stroppiano M, Cusano R, Filocamo M. Contribution of arylsulfatase A mutations located on the same allele to enzyme activity reduction and metachromatic leukodystrophy severity. Hum Genet. 2002; 110:351–355. PMID:
11941485.
Article
16. Gieselmann V, Polten A, Kreysing J, von Figura K. Arylsulfatase A pseudodeficiency: loss of a polyadenylylation signal and N-glycosylation site. Proc Natl Acad Sci USA. 1989; 86:9436–9440. PMID:
2574462.
Article
17. Ricketts MH, Amsterdam JD, Park DS, Yang RS, Poretz RD, Zhang X, et al. A novel arylsulfatase A protein variant and genotype in two patients with major depression. J Affect Disord. 1996; 40:137–147. PMID:
8897113.
Article